Centaurus Financial, Inc. Novartis Ag Transaction History

Centaurus Financial, Inc.

  • $1.44 Billion
  • Q3 2024

A detailed history of Centaurus Financial, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Centaurus Financial, Inc. holds 5,728 shares of NVS stock, worth $594,623. This represents 0.05% of its overall portfolio holdings.

Number of Shares
5,728
Previous 5,630 1.74%
Holding current value
$594,623
Previous $599,000 9.85%
% of portfolio
0.05%
Previous 0.04%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$106.13 - $120.89 $10,400 - $11,847
98 Added 1.74%
5,728 $658,000
Q2 2024

Sep 20, 2024
BUY
$92.57 - $107.37 $92,107 - $106,833
995 Added 21.47%
5,630 $599,000
Q1 2024

May 14, 2024
BUY
$95.27 - $108.47 $84,218 - $95,887
884 Added 23.57%
4,635 $448,000
Q4 2023

Feb 26, 2024
SELL
$92.27 - $101.54 $6,920 - $7,615
-75 Reduced 1.96%
3,751 $378,000
Q3 2023

Nov 13, 2023
BUY
$94.73 - $105.13 $30,218 - $33,536
319 Added 9.1%
3,826 $390,000
Q2 2023

Aug 15, 2023
SELL
$92.52 - $104.91 $90,114 - $102,182
-974 Reduced 21.74%
3,507 $353,000
Q1 2023

May 17, 2023
BUY
$80.03 - $92.81 $108,440 - $125,757
1,355 Added 43.35%
4,481 $412,000
Q4 2022

Feb 10, 2023
SELL
$75.55 - $92.52 $66,332 - $81,232
-878 Reduced 21.93%
3,126 $283,000
Q3 2022

Dec 05, 2022
BUY
$74.61 - $87.26 $100,648 - $117,713
1,349 Added 50.81%
4,004 $304,000
Q2 2022

Aug 02, 2022
BUY
$80.52 - $93.75 $213,780 - $248,906
2,655 New
2,655 $224,000
Q3 2020

Nov 12, 2020
SELL
$82.14 - $91.0 $802,425 - $888,979
-9,769 Closed
0 $0
Q2 2020

Aug 13, 2020
SELL
$80.93 - $91.1 $161 - $182
-2 Reduced 0.02%
9,769 $853,000
Q1 2020

Apr 21, 2020
SELL
$70.67 - $99.01 $199,501 - $279,505
-2,823 Reduced 22.42%
9,771 $806,000
Q4 2019

Feb 12, 2020
BUY
$84.35 - $95.37 $463,587 - $524,153
5,496 Added 77.43%
12,594 $1.19 Million
Q3 2019

Nov 12, 2019
BUY
$85.54 - $94.26 $471,667 - $519,749
5,514 Added 348.11%
7,098 $617,000
Q2 2019

Aug 15, 2019
BUY
$75.4 - $92.8 $109,179 - $134,374
1,448 Added 1064.71%
1,584 $145,000
Q1 2019

Jul 01, 2019
SELL
$75.32 - $86.15 $96,560 - $110,444
-1,282 Reduced 90.41%
136 $1.42 Million
Q1 2019

May 13, 2019
BUY
$75.32 - $86.15 $96,710 - $110,616
1,284 Added 958.21%
1,418 $136,000
Q4 2018

Feb 12, 2019
BUY
$73.66 - $82.02 $9,796 - $10,908
133 Added 13300.0%
134 $2,000
Q3 2018

Nov 05, 2018
SELL
$66.94 - $77.43 $209,723 - $242,588
-3,133 Reduced 99.97%
1 $108,000
Q2 2018

Aug 15, 2018
BUY
$64.91 - $73.36 $203,427 - $229,910
3,134 New
3,134 $237,000

Others Institutions Holding NVS

# of Institutions
1,437
Shares Held
133M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $223B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Centaurus Financial, Inc. Portfolio

Follow Centaurus Financial, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centaurus Financial, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Centaurus Financial, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email